Literature DB >> 18446342

Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreement.

Sotirios Bisdas1, Katarina Surlan-Popovic, Vojko Didanovic, Thomas J Vogl.   

Abstract

Our purpose was to determine the repeatability of squamous cell cancer in head and neck (SCCHN) and muscle tissue vascularity measurements as well as the inter- and intra-observer agreement using dynamic contrast-enhanced (DCE) multi-detector CT (MDCT). Twelve patients with histologically proven SCCHN were twice examined within 46 h. Measurement error and repeatability were assessed for each of the four functional parameters using the Bland-Altman plots. Two independent observers recorded the vascularity values of the tumor tissue; inter- and intra-observer agreement was assessed using the Bland-Altman plot analysis and intraclass correlation coefficients. For the tumor, the mean difference (95% limits of agreement) was 0.40 ml/min/100 g tissue (-6.80, 9.60); 0.01 (-0.96, 0.97) ml/100 g tissue; 0.20 (-1.80, 2.30) s; and 0.40 (-2.00, 2.80) ml/min/100 g tissue for BF, BV, MTT, and PS, respectively. For the muscle, the mean difference (95% limits of agreement) was -0.18 (-1.70, 1.35), 0.04 (-1.17, 1.35), -0.10 (-5.80, 5.60), and -0.10 (-2.20, 2.00), respectively. Measurement changes of at least +/-8%, 30%, 36%, and 13% were found to be significant for BF, BV, MTT, and PS, respectively. There was better intra- than inter-observer agreement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446342     DOI: 10.1007/s00330-008-0990-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

Review 1.  Perfusion CT: a worthwhile enhancement?

Authors:  K A Miles; M R Griffiths
Journal:  Br J Radiol       Date:  2003-04       Impact factor: 3.039

2.  Perfusion CT for head and neck tumors: pilot study.

Authors:  Zoran Rumboldt; Riyadh Al-Okaili; John P Deveikis
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

3.  Dynamic CT measurement of cerebral blood flow: a validation study.

Authors:  A Cenic; D G Nabavi; R A Craen; A W Gelb; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

4.  Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model.

Authors:  Zuxing Kan; Sith Phongkitkarun; Satoshi Kobayashi; Yi Tang; Lee M Ellis; Ting Y Lee; Chusilp Charnsangavej
Journal:  Radiology       Date:  2005-10       Impact factor: 11.105

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage?

Authors:  Quan Sing Ng; Vicky Goh; Ernst Klotz; Heinz Fichte; Michele I Saunders; Peter J Hoskin; Anwar R Padhani
Journal:  AJR Am J Roentgenol       Date:  2006-10       Impact factor: 3.959

7.  Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement.

Authors:  Vicky Goh; Steve Halligan; Jo-Ann Hugill; Paul Bassett; Clive I Bartram
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

8.  Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?

Authors:  A Zima; R Carlos; D Gandhi; I Case; T Teknos; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

9.  Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

Authors:  Jeremy J Erasmus; Gregory W Gladish; Lyle Broemeling; Bradley S Sabloff; Mylene T Truong; Roy S Herbst; Reginald F Munden
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

10.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G C Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G J Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  7 in total

1.  Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements.

Authors:  S Bisdas; Z Rumboldt; K Surlan-Popovic; M Baghi; T S Koh; T J Vogl; M G Mack
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

2.  Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy.

Authors:  K Surlan-Popovic; S Bisdas; Z Rumboldt; T S Koh; P Strojan
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

3.  Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis.

Authors:  Vicky Goh; Bal Sanghera; David M Wellsted; Josefin Sundin; Steve Halligan
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

4.  Detection of cartilage invasion in laryngeal carcinoma with dynamic contrast-enhanced CT.

Authors:  Jan W Dankbaar; Jaap Oosterbroek; Elise A Jager; Hugo W de Jong; Cornelis P Raaijmakers; Stefan M Willems; Chris H Terhaard; Marielle E Philippens; Frank A Pameijer
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-31

5.  Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma.

Authors:  Peter Popovic; Ana Leban; Klara Kregar; Manca Garbajs; Rok Dezman; Matjaz Bunc
Journal:  Radiol Oncol       Date:  2017-12-07       Impact factor: 2.991

6.  Observer variability of reference tissue selection for relativecerebral blood volume measurements in glioma patients.

Authors:  Marcel T H Oei; Frederick J A Meijer; Jan-Jurre Mordang; Ewoud J Smit; Albert J S Idema; Bozena M Goraj; Hendrik O A Laue; Mathias Prokop; Rashindra Manniesing
Journal:  Eur Radiol       Date:  2018-03-23       Impact factor: 5.315

7.  Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.

Authors:  K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.